Heng, Yu Jing Jan
- Beth Israel Deaconess Medical Center · Internal Medicine (topic-inferred)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #20,678
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$590.3K
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#20,678
By linked amount among FY2023 PIs
Earliest Year Loaded
2022
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Heng, Yu Jing Jan as a PI. Multi-PI records show the full award amount for context.
- 1R56CA284564-01R56Contact PIGender-Affirming Testosterone Therapy on Breast Cancer Risk and Treatment OutcomesBeth Israel Deaconess Medical Center · Internal Medicine (topic-inferred)$299.9Kaward amount
- 5R21CA267088-02R21Contact PIGender-affirming estrogen therapy and breast cancer treatment outcomeBeth Israel Deaconess Medical Center · Internal Medicine (topic-inferred)$200.4Kaward amount
- 3R21CA267088-02S1R21Contact PIAdmin Suppl Gender-affirming estrogen therapy and breast cancer treatment outcomeBeth Israel Deaconess Medical Center · Internal Medicine (topic-inferred)$89.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Heng, Yu Jing Jan as a PI.
FY2023 award administered by Beth Israel Deaconess Medical Center (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardBeth Israel Deaconess Medical Center
- 2023$500K Cumulative Funding